BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11561765)

  • 21. [A clinico-pathological study of neuroendocrine tumors in stomach].
    Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.
    Tartaglia A; Portela-Gomes GM; Oberg K; Vezzadini P; Foschini MP; Stridsberg M
    Virchows Arch; 2006 Apr; 448(4):399-406. PubMed ID: 16408221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary tumorlet associated with second neoplasia].
    Pitzzu M; Ferreira Y; Sánchez MC; Saccoliti M; Spizzamiglio N; Galmes M; Abalovich M; O'Leary K; Jankilevich G
    Medicina (B Aires); 2017; 77(4):341-343. PubMed ID: 28825583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine tumours of the stomach.
    Bordi C
    Pathol Res Pract; 1995 May; 191(4):373-80. PubMed ID: 7479354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.
    Qvigstad G; Qvigstad T; Westre B; Sandvik AK; Brenna E; Waldum HL
    APMIS; 2002 Feb; 110(2):132-9. PubMed ID: 12064868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction which was successfully treated with somatostatin analogue.
    Hirai R; Haruma K; Okada H; Itakura J; Mizuno M
    Clin J Gastroenterol; 2022 Apr; 15(2):363-367. PubMed ID: 34982362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats.
    Fossmark R; Zhao CM; Martinsen TC; Kawase S; Chen D; Waldum HL
    APMIS; 2005 Jun; 113(6):436-49. PubMed ID: 15996161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in clinicopathological study on gastric endocrine neoplasms].
    Yu J; Wang L
    Zhonghua Bing Li Xue Za Zhi; 1997 Jun; 26(3):185-6. PubMed ID: 10072860
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hyperplastic polyp with neoplastic transformation in a patient with atrophic gastritis and multiple gastric neuroendocrine tumors].
    Moura EG; Domingos TA; Alvarado H; Iriya K; Kishi HS; Martins BC; Moura ET; P PS
    Rev Gastroenterol Mex; 2012; 77(2):96-8. PubMed ID: 22658549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx.
    Hunt JL; Ferlito A; Hellquist H; Rinaldo A; Skálová A; Slootweg PJ; Willems SM; Cardesa A
    Adv Anat Pathol; 2017 May; 24(3):161-168. PubMed ID: 28338500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21 and p27 immunoexpression in gastric well differentiated endocrine tumors (ECL-cell carcinoids).
    Doganavsargil B; Sarsik B; Kirdok FS; Musoglu A; Tuncyurek M
    World J Gastroenterol; 2006 Oct; 12(39):6280-4. PubMed ID: 17072949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Type 1 carcinoids and ECL-cell hyperplasia of the gastric mucosa].
    Stachura T; Strzałka M; Bolt L
    Przegl Lek; 2003; 60(12):782-8. PubMed ID: 15058016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should gastric carcinoid tumors associated with pernicious anemia be treated aggressively?
    Stalnikowicz R; Eliakim R; Steiner D; Gross D; Okon E
    J Clin Gastroenterol; 1987 Oct; 9(5):521-5. PubMed ID: 3680900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric Carcinoids.
    Grozinsky-Glasberg S; Alexandraki KI; Angelousi A; Chatzellis E; Sougioultzis S; Kaltsas G
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition and the histopathologic classification of ECL cell proliferations.
    Dayal Y
    Yale J Biol Med; 1998; 71(3-4):257-72. PubMed ID: 10461357
    [No Abstract]   [Full Text] [Related]  

  • 39. Amphicrine gastric carcinoma.
    Reis-Filho JS; Schmitt FC
    Arch Pathol Lab Med; 2001 Nov; 125(11):1513-4. PubMed ID: 11698020
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
    Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
    Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.